These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 22024702)
21. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research. Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841 [TBL] [Abstract][Full Text] [Related]
22. Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects. Park KH; Ryu E; Tosakulwong N; Wu Y; Edwards AO Mol Vis; 2009; 15():200-7. PubMed ID: 19169411 [TBL] [Abstract][Full Text] [Related]
23. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population. Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979 [TBL] [Abstract][Full Text] [Related]
25. Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. Ermini L; Goodship TH; Strain L; Weale ME; Sacks SH; Cordell HJ; Fremeaux-Bacchi V; Sheerin NS Mol Immunol; 2012 Jan; 49(4):640-8. PubMed ID: 22153652 [TBL] [Abstract][Full Text] [Related]
26. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours. Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099 [TBL] [Abstract][Full Text] [Related]
27. [Polymorphisms of complement factor genes and age-related macular degeneration in a German population]. Baatz H; Poupel L; Coudert M; Sennlaub F; Combadiere C Klin Monbl Augenheilkd; 2009 Aug; 226(8):654-8. PubMed ID: 19399715 [TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Cipriani V; Leung HT; Plagnol V; Bunce C; Khan JC; Shahid H; Moore AT; Harding SP; Bishop PN; Hayward C; Campbell S; Armbrecht AM; Dhillon B; Deary IJ; Campbell H; Dunlop M; Dominiczak AF; Mann SS; Jenkins SA; Webster AR; Bird AC; Lathrop M; Zelenika D; Souied EH; Sahel JA; Léveillard T; ; Cree AJ; Gibson J; Ennis S; Lotery AJ; Wright AF; Clayton DG; Yates JR Hum Mol Genet; 2012 Sep; 21(18):4138-50. PubMed ID: 22694956 [TBL] [Abstract][Full Text] [Related]
29. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration. Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095 [TBL] [Abstract][Full Text] [Related]
30. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration]. Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491 [TBL] [Abstract][Full Text] [Related]
31. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL Hum Mol Genet; 2007 Aug; 16(16):1986-92. PubMed ID: 17576744 [TBL] [Abstract][Full Text] [Related]
32. Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease. Winkler TW; Grassmann F; Brandl C; Kiel C; Günther F; Strunz T; Weidner L; Zimmermann ME; Korb CA; Poplawski A; Schuster AK; Müller-Nurasyid M; Peters A; Rauscher FG; Elze T; Horn K; Scholz M; Cañadas-Garre M; McKnight AJ; Quinn N; Hogg RE; Küchenhoff H; Heid IM; Stark KJ; Weber BHF BMC Med Genomics; 2020 Aug; 13(1):120. PubMed ID: 32843070 [TBL] [Abstract][Full Text] [Related]
33. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice. Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy. Bellone S; Roque D; Cocco E; Gasparrini S; Bortolomai I; Buza N; Abu-Khalaf M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD Br J Cancer; 2012 Apr; 106(9):1543-50. PubMed ID: 22531721 [TBL] [Abstract][Full Text] [Related]
35. Associations of 6p21.3 Region with Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Ye Z; Shuai P; Zhai Y; Li F; Jiang L; Lu F; Wen F; Huang L; Zhang D; Liu X; Lin Y; Luo H; Zhang H; Zhu X; Wu Z; Yang Z; Gong B; Shi Y Sci Rep; 2016 Feb; 6():20914. PubMed ID: 26861912 [TBL] [Abstract][Full Text] [Related]
36. Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome. Michielsen LA; van Zuilen AD; Kardol-Hoefnagel T; Verhaar MC; Otten HG Front Immunol; 2018; 9():972. PubMed ID: 29867953 [TBL] [Abstract][Full Text] [Related]
37. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration. Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ; JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084 [TBL] [Abstract][Full Text] [Related]
38. Complement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration. Marioli DI; Pharmakakis N; Deli A; Havvas I; Zarkadis IK Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1547-53. PubMed ID: 19568762 [TBL] [Abstract][Full Text] [Related]
39. Association of copy number variations in complement factor H-Related genes among age-related macular degenerative subjects. Bakri NM; Ramachandran V; Kee HF; Subrayan V; Isa H; Ngah NF; Mohamad NA; Mooi CS; Mun CY; Ismail P; Ismail F; Sukiman ES; Wan Sulaiman WA Kaohsiung J Med Sci; 2017 Dec; 33(12):602-608. PubMed ID: 29132549 [TBL] [Abstract][Full Text] [Related]
40. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration. Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]